Published: 26 July 2019
Publications
Information released under the OIA on sodium valproate (Epilim)
Medsafe is publishing documents released under the OIA requesting information on sodium valproate (Epilim).
- OIA letter regarding sodium valproate (Epilim) (PDF 5,045 KB, 8 pages)
- DAAC minutes (PDF 36,454 KB, 81 pages)
- Medsafe mailouts (PDF 47,241 KB, 119 pages)
- Internal correspondence (PDF 166,355 KB, 67 pages)
- Media correspondence (PDF 36,086 KB, 56 pages)
- External correspondence (PDF 55,621 KB, 129 pages)
- Company correspondence (PDF 178,224 KB, 210 pages)
- MARC minutes (PDF 156,266 KB, 361 pages)
Submissions and advice, including Medsafe's response to the Health Select Committee following a petition requesting an inquiry into the numbers harmed by antiepileptic medicines during pregnancy can be accessed here: www.parliament.nz/en/pb/petitions/document/PET_78066/petition-of-denise-astill-inquiry-into-the-numbers-harmed
